John Poulos
Director/Board Member at FARON PHARMACEUTICALS OY
Net worth: 18 156 $ as of 2024-04-29
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Juho Markku Jalkanen | M | 46 | 21 years | |
| Gregory Brown | M | 70 |
Memgen, Inc.
 Memgen, Inc. Pharmaceuticals: MajorHealth Technology Memgen, Inc. operates as a clinical-stage biotech company. Its product ISF35, is a viral cancer immunotherapy encoding an optimized version of CD40 ligand. The company was founded by Robert C. Coates and is headquartered in Houston, TX. | 7 years |
| Robert C. Coates | M | - |
Memgen, Inc.
Memgen, Inc. Pharmaceuticals: MajorHealth Technology Memgen, Inc. operates as a clinical-stage biotech company. Its product ISF35, is a viral cancer immunotherapy encoding an optimized version of CD40 ligand. The company was founded by Robert C. Coates and is headquartered in Houston, TX. | 15 years |
| Markku Tapani Jalkanen | M | 70 | 21 years | |
| Mark Joseph Cantwell | M | 54 |
Memgen, Inc.
Memgen, Inc. Pharmaceuticals: MajorHealth Technology Memgen, Inc. operates as a clinical-stage biotech company. Its product ISF35, is a viral cancer immunotherapy encoding an optimized version of CD40 ligand. The company was founded by Robert C. Coates and is headquartered in Houston, TX. | - |
| Tuomo Tapani Pätsi | M | 60 | 1 years | |
| Maija-Leena Hollmén | M | - | 21 years | |
| Marie-Louise Fjaellskog | M | 59 | 2 years | |
| Christopher J. Pagano | M | 60 |
Memgen, Inc.
Memgen, Inc. Pharmaceuticals: MajorHealth Technology Memgen, Inc. operates as a clinical-stage biotech company. Its product ISF35, is a viral cancer immunotherapy encoding an optimized version of CD40 ligand. The company was founded by Robert C. Coates and is headquartered in Houston, TX. | - |
| Casey Logan | M | 52 |
Memgen, Inc.
Memgen, Inc. Pharmaceuticals: MajorHealth Technology Memgen, Inc. operates as a clinical-stage biotech company. Its product ISF35, is a viral cancer immunotherapy encoding an optimized version of CD40 ligand. The company was founded by Robert C. Coates and is headquartered in Houston, TX. | - |
| Vesa Tapio Karvonen | M | 52 | 2 years | |
| Patricia Bitar | F | 65 |
Memgen, Inc.
Memgen, Inc. Pharmaceuticals: MajorHealth Technology Memgen, Inc. operates as a clinical-stage biotech company. Its product ISF35, is a viral cancer immunotherapy encoding an optimized version of CD40 ligand. The company was founded by Robert C. Coates and is headquartered in Houston, TX. | - |
| Steven Whitley | M | - |
Memgen, Inc.
Memgen, Inc. Pharmaceuticals: MajorHealth Technology Memgen, Inc. operates as a clinical-stage biotech company. Its product ISF35, is a viral cancer immunotherapy encoding an optimized version of CD40 ligand. The company was founded by Robert C. Coates and is headquartered in Houston, TX. | - |
| Birge Berns | M | - | 1 years | |
| Christine Roth | F | 61 | 1 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Matti Esa Manner | M | 71 | 19 years | |
| Frank Armstrong | M | 67 | 9 years | |
| Leopoldo Giampaolo Zambeletti | M | 55 | 8 years | |
| Anne Michelle Whitaker | F | 56 | 2 years | |
| Katja Wallenlind | F | - | - | |
| Juhana Heinonen | M | - | - | |
| Jennifer Smith-Parker | F | - | 1 years | |
| Juuso Vakkuri | M | - | - | |
| Kevin Coveney | M | 60 |
Memgen, Inc.
Memgen, Inc. Pharmaceuticals: MajorHealth Technology Memgen, Inc. operates as a clinical-stage biotech company. Its product ISF35, is a viral cancer immunotherapy encoding an optimized version of CD40 ligand. The company was founded by Robert C. Coates and is headquartered in Houston, TX. | 1 years |
| Antti-Jussi Aro | M | 41 |
AbbVie Oy
 AbbVie Oy Pharmaceuticals: MajorHealth Technology Part of AbbVie, Inc., AbbVie Oy is a Finnish company that manufactures and wholesales pharmaceutical products. The private company is based in Espoo, Finland. | 4 years |
| Mikael Maksimow | M | - | 4 years | |
| Jami Mandelin | M | - | 5 years | |
| Olivier Jean Bohuon | M | 65 |
Abbott Pharmaceutical, Inc.
| 7 years |
| Erik Ostrowski | M | 51 | 2 years | |
| Toni Haenninen | M | - | 4 years | |
| James O'Brien | M | 57 | 1 years | |
| Julia Balanova | F | - | 1 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| Finland | 24 | 75.00% |
| United States | 9 | 28.13% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- John Poulos
- Personal Network
